Health1 min read

STAT+: FDA discloses reasons for rejecting Summit drug

By · Via STAT Health · Published by Everything Blog

In short

The Food and Drug Administration has publicly outlined the specific rationale behind rejecting a drug developed by Summit. This agency determination highlights notable regulatory activity currently impacting the broader biotechnology landscape. In an unrelated administrative shift, the Trump administration has officially withdrawn the nomination of Heidi Overton to serve as the agency's commissioner. Consequently, Overton has been entirely removed from consideration to lead the federal regulatory office.

Key points

  • Summit now has the official reasons behind the federal agency's decision to reject its dr…: Summit now has the official reasons behind the federal agency's decision to reject its drug.
  • The regulatory decision by the agency marks a notable development for the biotechnology i…: The regulatory decision by the agency marks a notable development for the biotechnology industry.
  • Heidi Overton is no longer being considered to take over the leadership role at the agenc…: Heidi Overton is no longer being considered to take over the leadership role at the agency.

Sources checked by our analysis pipeline: 1

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70.

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard. You can reach Adam on Signal at stataf.54.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. We got big news on the FDA last night — let’s get straight into it.

Advertisement

White House pulls nomination of Overton to lead FDA

The Trump administration is pulling its nomination of Heidi Overton to be FDA commissioner, my colleagues report.

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the…

Health